Danlian-Tongmai formula improves diabetic vascular calcification by regulating CCN3/NOTCH signal axis to inhibit inflammatory reaction
BackgroundVascular calcification (VC) commonly occurs in diabetes and is associated with cardiovascular disease incidence and mortality. Currently, there is no drug treatment for VC. The Danlian-Tongmai formula (DLTM) is a traditional Chinese medicine (TCM) prescription used for diabetic VC (DVC), b...
Saved in:
Main Authors: | Wenting Wang, Yiwen Li, Mengmeng Zhu, Qian Xu, Jing Cui, Yanfei Liu, Yue Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1510030/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CCN1 promotes APRIL/BAFF signaling in esophageal squamous cell carcinoma but attenuates it in esophageal adenocarcinoma
by: Lingling Xing, et al.
Published: (2025-01-01) -
CCN3: lactational bone booster
by: Nathan Xu, et al.
Published: (2024-12-01) -
Integrated analyses of Mendelian randomization, eQTL, and single-cell transcriptome identify CCN3 as a potential biomarker in aortic dissection
by: Haoyu Ran, et al.
Published: (2024-12-01) -
Generalized arterial calcification of infancy – Fetal diagnosis to postnatal management
by: Lamk Kadiyani, et al.
Published: (2024-12-01) -
Characteristics and prognostic values of abdominal aortic branches calcification in hemodialysis patients
by: Wen Shi, et al.
Published: (2025-12-01)